A case report of coronavirus disease‐2019‐induced acute asthma exacerbation in an obese patient

The coronavirus disease‐2019 (COVID‐19) has spread worldwide. Previous studies indicated a low prevalence of COVID‐19 induced acute exacerbations of asthma. We present a 39‐year‐old‐male obese asthmatic case who experienced acute asthma exacerbation during COVID‐19. On day 8 of infection, his cough...

Descripción completa

Detalles Bibliográficos
Autores principales: Sasaki, Hisashi, Miyata, Jun, Kobayashi, Ai, Kawano, Shuichi, Kawana, Akihiko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Ltd 2022
Materias:
Case Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9171688/
https://www.ncbi.nlm.nih.gov/pubmed/35685850
http://dx.doi.org/10.1002/rcr2.979
Descripción
Sumario:The coronavirus disease‐2019 (COVID‐19) has spread worldwide. Previous studies indicated a low prevalence of COVID‐19 induced acute exacerbations of asthma. We present a 39‐year‐old‐male obese asthmatic case who experienced acute asthma exacerbation during COVID‐19. On day 8 of infection, his cough and dyspnea worsened with hypoxia and wheezing. Laboratory test results revealed elevated interleukin‐6 (IL‐6) and total immunoglobulin E (IgE) levels without eosinophilia. Two months since the onset, hypoxia disappeared with decreased IL‐6 and IgE levels. Our case suggested that obesity and high serum IL‐6 and IgE levels may have contributed to atypical asthma exacerbation in COVID‐19.

Ejemplares similares